As we reported recently that Tregs from RRMS patients are more susceptible to TLR2-stimulation than those of HC (19), we explored whether CD4+ T cells may have potential to contribute to the circulating pool of sTLR2. Here, CD4 is linked to relapsing-remitting multiple sclerosis.